Carbapenem therapy for bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae

Nan Yao Lee; Wei Han Huang; Ko Chung Tsui; Po Ren Hsueh; Wen Chien Ko

doi:10.1016/j.diagmicrobio.2010.12.008

Carbapenem therapy for bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae

Nan Yao Lee, Wei Han Huang, Ko Chung Tsui, Po Ren Hsueh, Wen Chien Ko

Department of Internal Medicine

Research output: Contribution to journal › Article › peer-review

25 Citations (Scopus)

Abstract

For 244 patients with bacteremia due to extended-spectrum β-lactamase (ESBL)-producing Escherichia coli or Klebsiella pneumoniae treated by ertapenem (73, 29.9%) or either imipenem or meropenem (171, 70.1%), the therapeutic efficacy was evaluated. Ertapenem therapy was effective for patients with ESBL-producing E. coli or K. pneumoniae bacteremia in terms of mortality and microbiological responses, as compared with imipenem or meropenem.

Original language	English
Pages (from-to)	150-153
Number of pages	4
Journal	Diagnostic Microbiology and Infectious Disease
Volume	70
Issue number	1
DOIs	https://doi.org/10.1016/j.diagmicrobio.2010.12.008
Publication status	Published - 2011 May

All Science Journal Classification (ASJC) codes

Microbiology (medical)
Infectious Diseases

Access to Document

10.1016/j.diagmicrobio.2010.12.008

Cite this

@article{2dd77a39a05940e7ad62f50faa147c3c,

title = "Carbapenem therapy for bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae",

abstract = "For 244 patients with bacteremia due to extended-spectrum β-lactamase (ESBL)-producing Escherichia coli or Klebsiella pneumoniae treated by ertapenem (73, 29.9%) or either imipenem or meropenem (171, 70.1%), the therapeutic efficacy was evaluated. Ertapenem therapy was effective for patients with ESBL-producing E. coli or K. pneumoniae bacteremia in terms of mortality and microbiological responses, as compared with imipenem or meropenem.",

author = "Lee, {Nan Yao} and Huang, {Wei Han} and Tsui, {Ko Chung} and Hsueh, {Po Ren} and Ko, {Wen Chien}",

year = "2011",

month = may,

doi = "10.1016/j.diagmicrobio.2010.12.008",

language = "English",

volume = "70",

pages = "150--153",

journal = "Diagnostic Microbiology and Infectious Disease",

issn = "0732-8893",

publisher = "Elsevier Inc.",

number = "1",

}

TY - JOUR

T1 - Carbapenem therapy for bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae

AU - Lee, Nan Yao

AU - Huang, Wei Han

AU - Tsui, Ko Chung

AU - Hsueh, Po Ren

AU - Ko, Wen Chien

PY - 2011/5

Y1 - 2011/5

N2 - For 244 patients with bacteremia due to extended-spectrum β-lactamase (ESBL)-producing Escherichia coli or Klebsiella pneumoniae treated by ertapenem (73, 29.9%) or either imipenem or meropenem (171, 70.1%), the therapeutic efficacy was evaluated. Ertapenem therapy was effective for patients with ESBL-producing E. coli or K. pneumoniae bacteremia in terms of mortality and microbiological responses, as compared with imipenem or meropenem.

AB - For 244 patients with bacteremia due to extended-spectrum β-lactamase (ESBL)-producing Escherichia coli or Klebsiella pneumoniae treated by ertapenem (73, 29.9%) or either imipenem or meropenem (171, 70.1%), the therapeutic efficacy was evaluated. Ertapenem therapy was effective for patients with ESBL-producing E. coli or K. pneumoniae bacteremia in terms of mortality and microbiological responses, as compared with imipenem or meropenem.

UR - http://www.scopus.com/inward/record.url?scp=79955028237&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955028237&partnerID=8YFLogxK

U2 - 10.1016/j.diagmicrobio.2010.12.008

DO - 10.1016/j.diagmicrobio.2010.12.008

M3 - Article

C2 - 21398070

AN - SCOPUS:79955028237

SN - 0732-8893

VL - 70

SP - 150

EP - 153

JO - Diagnostic Microbiology and Infectious Disease

JF - Diagnostic Microbiology and Infectious Disease

IS - 1

ER -

Carbapenem therapy for bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this